Insurance Period in Obesity Treatment
"For Health Insurances and Employers: GLP-1 Guide in Weight Management" was published by the Turkish Obesity Research Association (TOAD) and Aon Turkey Health with the support of Novo Nordisk.

The guide, which defines obesity as a chronic disease rather than a cosmetic problem and provides a scientific road map for private health insurance coverage, is the first and only comprehensive study in Türkiye that brings together the insurance and employer sides in obesity management.This guide, prepared on the effectiveness of new generation GLP-1 treatments in weight management, focuses on how insurance companies and employers can make health policies more inclusive. The guide emphasizes the need to overcome stigma, privacy and access barriers by focusing on employee experience. At this point, the employer's role is not only limited to creating a supportive culture, but also stands out as supporting health policies and measurement approaches with clinical data.
New Standard in Preventive Health
This guide, which offers a new coverage and access design for private health insurances and employers, positions the inclusion of GLP-1 treatments in policies as a strategic investment, not an expense item. While it is reminded that excluding obesity from the scope makes it difficult to follow up more than 200 secondary diseases caused by obesity; The importance of the balance established between short-term costs and long-term health outcomes is expressed. Just like the social benefit provided by the inclusion of the HPV vaccine in insurance coverage, weight management is becoming a standard part of modern insurance and preventive health.
“A reliable practice guide for the insurance industry”
"Obesity is considered a 'chronic, progressive and serious disease that needs to be treated' by medical authorities around the world," said Novo Nordisk Turkey. Senior Medical Director Dr. This guide, which we implemented with the scientific partnership of TOAD and Aon Türkiye under the sponsorship of Ömer Buğra Bahadır, Novo Nordisk; While it increases the accessibility of modern treatments within a scientific framework, it also offers an evidence-based, reliable application guide for the insurance industry and employers. Our aim is to make a sustainable contribution to public health by making obesity management a standard part of health policies in Türkiye.” he said.
Sigortada Bugün'un sağlık editörü. Tamamlayıcı sağlık sigortası, SGK düzenlemeleri ve sağlık sektöründeki gelişmeleri takip ederek sigorta ile sağlık arasındaki köprüyü kuruyor.
All articles →Comments (0)
Sign in to comment
No comments yet. Be the first to comment!
Related Articles
Complementary policy period begins in private health insurance

This disease leads to corneal transplantation

ONE CONTROL, ONE LIFE IN BREAST CANCER!

Why Are Relationships Short-Lived in the Modern Age?

Summer heat increases the risk of heat rash in babies

